dm+d

Unassigned

New Medicines

StravixAcute or chronic wounds, damaged or inadequate integument tissue - first-line

Information

Stravix
New molecular entity
Osiris
Osiris

Development and Regulatory status

None
None
Launched

Mar 19: No plans for EU or UK licence applications discussed in Osiris annual 10K report [3].


Mar 18: No plans for EU or UK licence applications discussed in Osiris annual 10K report [2].


Nov 15: Launched in US for soft tissue repair [1].

Category

A cryopreserved human placental tissue comprised of amniotic and connective layers of umbilical tissue. Stravix conforms to the site of injury, requires minimal preparation prior to use and is stored at -75°C to -85°C.
Acute or chronic wounds, damaged or inadequate integument tissue - first-line
Topical